BioProject

• SARS-CoV-2 from Germany
  SARS-CoV-2 from Germany

  SARS-CoV-2 was grown by inoculation of VeroE6 cells with 200 µl nasopharyngeal swab of a COVID-19 patient.
  BioProject
• Severe acute respiratory syndrome coronavirus 2
  Severe acute respiratory syndrome coronavirus 2

  Severe acute respiratory syndrome coronavirus 2 Raw sequence reads
  BioProject
• Severe acute respiratory syndrome coronavirus 2 strain:Gamma
  Severe acute respiratory syndrome coronavirus 2 strain:Gamma

  Severe acute respiratory syndrome coronavirus 2 strain:Gamma Raw sequence reads
  BioProject
• SARS-CoV-2 point mutation and deletion spectra, and their association with diffe...
  SARS-CoV-2 point mutation and deletion spectra, and their association with different disease outcome

  The study shows that mutant spectra of SARS-CoV-2 from diagnostic samples differed in point mutation abundance and complexity, and that significantly larger values were recorded in virus from patients who developed mild COVID-19 symptoms. The abundance of low frequency mutations marks a difference with other RNA viruses, and it may slow down the response of SARS-CoV-2 to escape specific selective constraints such as drugs or antibodies.
  BioProject

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on